Last Updated:
Searching
Create account to add to watchlist!
Create account to add to watchlist!

Lazard Growth Acquisition Corp. I - LGAC

  • Commons

    $9.92

    +0.00%

    LGAC Vol: 0.0

  • Warrants

    $0.07

    -4.76%

    LGACW Vol: 200.0

  • Units

    $9.92

    +0.09%

    LGACU Vol: 300.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 569.8M
Average Volume: 323.8K
52W Range: $9.68 - $9.92
Weekly %: +0.10%
Monthly %: +0.35%
Inst Owners: 118

Info

Target: Searching
Days Since IPO: 595
Unit composition:
Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant
Trust Size: 50000000.0M

đŸ•”Stocktwit Mentions

dividendinvestorbyeagle posted at 2022-09-27T15:20:04Z

$LGAC hit 52 week high (Cl A/Lazard Growth Acquisition Corp I) https://www.dividendinvestor.com/dividend-news/?symbol=lgac

dividendinvestorbyeagle posted at 2022-09-14T12:17:59Z

$LGAC hit 52 week high (Cl A/Lazard Growth Acquisition Corp I) https://www.dividendinvestor.com/dividend-news/?symbol=lgac

dividendinvestorbyeagle posted at 2022-09-06T13:20:52Z

$LGAC hit 52 week high (Cl A/Lazard Growth Acquisition Corp I) https://www.dividendinvestor.com/dividend-news/?symbol=lgac

Last10K posted at 2022-08-11T01:23:22Z

$LGAC just filed a 10-Q Quarterly Report with 5 financial statements and 22 disclosures. Access them all or just read their earnings: https://last10k.com/sec-filings/lgac/0001564590-22-028939.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=lgac

stockilluminati posted at 2022-08-10T20:42:08Z

$LGAC https://www.stockilluminati.com/lgac/filings.php - Lazard Growth Acquisition Corp. I - Ordinary Shares files form 10-Q today, check out the details.

Quantisnow posted at 2022-08-10T20:12:08Z

$LGAC 📜 SEC Form 10-Q filed by Lazard Growth Acquisition Corp. I https://quantisnow.com/i/3266176?utm_source=stocktwits 45 seconds delayed.

Newsfilter posted at 2022-08-10T20:11:18Z

$LGAC Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC https://newsfilter.io/a/18361c7b485827bec42cad9f8faaaef4

MariaC82 posted at 2022-06-07T16:48:33Z

Vol Ratio Leaders (exc 10dy avg vol. a/o12:38pmEST): $KRBP $HLBZ $JAN $LGAC $SYTA

Last10K posted at 2022-05-11T22:14:44Z

$LGAC just filed a 10-Q Quarterly Report with 47 sections and 4 exhibits. Access them all or just read their earnings: https://last10k.com/sec-filings/lgac/0001564590-22-019555.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=lgac

cctranscripts posted at 2022-05-11T21:42:27Z

Lazard Growth Acquisition Corp. I Just Filed Its Quarterly Report: Net Income Per Ordin... https://www.conferencecalltranscripts.com/summary/?id=10831450 $LGAC

Quantisnow posted at 2022-05-11T21:03:28Z

$LGAC 📜 SEC Form 10-Q filed by Lazard Growth Acquisition Corp. I https://quantisnow.com/i/2871469?utm_source=stocktwits 45 seconds delayed.

risenhoover posted at 2022-05-11T21:03:16Z

$LGAC / Lazard Growth Acquisition I files form 10-Q https://fintel.io/sf/us/lgac?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

Newsfilter posted at 2022-05-11T21:02:40Z

$LGAC Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC https://newsfilter.io/a/af15c85de7f3c25a424a266553d98161

Management

Our officers, directors and director nominees are as follows: Name Age Position Alexander Stern 54 Executive Chairman of the Board Eyal Ofir 40 Chief Executive Officer and Director Mary Ann Deignan 58 Chief Financial Officer and Director Adam Berlew 54 Director Nominee* Pierre-Yves Cros 61 Director Nominee* Philip Hadley 58 Director Nominee* Noreen Roth Henig 55 Director Nominee* Selina Tobaccowala 44 Director Nominee* * This individual will occupy the position of director on the effective date of the registration statement of which this prospectus is a part. Alexander Stern serves as our Executive Chairman. Mr. Stern has served as President of Lazard Ltd and Lazard Group since June 2019 and as a Managing Director of Lazard since 2002. Mr. Stern has previously served in various other leadership capacities at Lazard, including Chief Executive Officer of Lazard’s financial advisory business, Chief Operating Officer of Lazard and Global Head of Strategy of Lazard. Mr. Stern is recognized as a proven financial advisor in the technology sector with a track record of leading complex transformational growth and value creation initiatives for clients. Prior to joining Lazard, Mr. Stern held various positions with Patricof & Co. Ventures and IBM. Mr. Stern is Chairman of the LUNGevity Foundation and a member of the Board of Advisors for the School of Engineering and Applied Sciences of the University of Pennsylvania. Mr. Stern earned a B.S. from Duke University, an M.S.E. from the School of Engineering and Applied Science at the University of Pennsylvania and an M.B.A. from the University of Pennsylvania, Wharton School. Mr. Stern was selected to serve on our board of directors due to his technology sector expertise and experience leading growth and value creation initiatives, including in his current role at Lazard where he is responsible for developing and implementing the firm’s growth strategy. Eyal Ofir serves as our Chief Executive Officer and a Director. Mr. Ofir is a Managing Director in Lazard’s Financial Institutions Group where he advises a broad range of global financial institutions, specializing in fintech. Over the course of his career, Mr. Ofir has advised on a multitude of mergers, acquisitions, divestitures, leverage buyouts, IPOs and other capital market transactions. Prior to joining Lazard, Mr. Ofir worked in Ernst & Young’s Transaction Advisory Services group and served as a Captain in the Israeli Navy. Mr. Ofir serves as Director and Treasurer of the National Psoriasis Foundation and as a member of Investment Committee for the endowment of Hadassah, the Women’s Zionist Organization of America, Inc. Mr. Ofir received a B.A. from the Hebrew University of Jerusalem with a double major in Economics and Accounting and an M.B.A. from the University of Chicago Booth School of Business, where he was a Dennis W. and Jane B. Carlton Fellow. Mr. Ofir was selected to serve on our board of directors due to his financial services sector expertise and substantial experience in mergers, acquisitions and capital market transactions. Mary Ann Deignan serves as our Chief Financial Officer and a Director. Ms. Deignan is a Managing Director and Co-Head of Capital Markets Advisory at Lazard, advising clients on shareholder activism, strategic investor relations, capital raising and corporate governance. Ms. Deignan joined Lazard from Bank of America Merrill Lynch, where she was Co-Head of Global Equity Capital Markets, a role she assumed after her tenure as Head of Americas Equity Capital Markets. She also worked for UBS as Head of Americas Equity Capital Markets. Ms. Deignan began her career at Bankers Trust in leveraged finance. Ms. Deignan provides expert guidance across regions and market sectors on a range of shareholder and corporate finance matters including 119 Table of Contents activism preparedness and defense, investor perspectives on M&A and strategic actions, IPO advisory and capital raising, trends in ESG and corporate governance. Ms. Deignan has extensive knowledge of the global equity markets and public market investors. Ms. Deignan is on the Investment Committee of the Margaret A. Cargill Philanthropies and the Board of Advisors at the Hospital for Special Surgery in NYC. She has a B.A. from Mount Holyoke College and an M.B.A. from the Tuck School at Dartmouth. Ms. Deignan was selected to serve on our board of directors due to her extensive knowledge of the global equity markets and public markets investors through her experience advising clients on shareholder activism, strategic investor relations, capital raising and corporate governance. Adam Berlew has agreed to serve on our board of directors on the effective date of the registration statement of which this prospectus is a part. Mr. Berlew is currently Director of Cloud AI & Industry Solutions at Google, Inc., where he leads strategic customer and partner engagement, operations and product inclusion. Mr. Berlew previously served as the Director of Global Enterprise Demand Marketing for Google Cloud from 2017 to 2021. Prior to Google Cloud, he served as the Vice President of Global Marketing and Customer Engagement with Broadcom Inc. from 2015 to 2017. Prior to joining Broadcom Inc., he served as Vice President of Global Demand Generation & Americas Marketing with Equinix Inc., a data center company. Mr. Berlew began his career working at the Boston Consulting Group and has also been a tenured marketing leader with Dell Inc. Mr. Berlew holds a B.A. in Economics with Honors from Brown University and an M.B.A. from the University of Pennsylvania, Wharton School. He has served as a member of the board of directors of Stifel Financial Corporation’s since 2019 and as one of the U.S. Olympic Luge Committee’s independent board members since 2014. Mr. Berlew was selected to serve on our board of directors due to his extensive management and business background, particularly in the cloud, high-tech, telecom and financial and professional services sectors. Pierre-Yves Cros has agreed to serve on our board of directors on the effective date of the registration statement of which this prospectus is a part. Mr. Cros is a Senior Advisor at The Blackstone Group Inc., one of the world’s leading investment firms. Prior to The Blackstone Group Inc., Mr. Cros was Chief Strategy and Development Officer at Capgemini Group, a Paris-based company that provides consulting, digital transformation, technology and engineering services, where he held various senior leadership positions from 2003 to 2020. Mr. Cros received an M.Sc. in Civil Engineering from Institut National des Sciences AppliquĂ©es de Lyon and an M.B.A. from HEC Paris. Mr. Cros was selected to serve on our board of directors due to his substantial experience in mergers and acquisitions, operations and strategic business planning, as well as his Continental European perspective from his leadership positions in multi-national businesses. Philip Hadley has agreed to serve on our board of directors on the effective date of the registration statement of which this prospectus is a part. Mr. Hadley is currently a Senior Advisor to Oak Hill Capital and a Special Advisor to Brighton Park Capital. Mr. Hadley was previously the Chairman and CEO at FactSet Research Systems Inc., a financial data and software company, where he held various leadership positions from November 1986 to June 2020. Prior to joining FactSet Research Systems Inc., Mr. Hadley was employed by Cargill Corporation. Mr. Hadley received a B.B.A. in Accounting from the University of Iowa and is a Chartered Financial Analyst. He has served as the Chairman of Clean Origin since 2018, the Chairman of RocketReach.co since 2020, a member of the board of directors of Calero Software since 2020 and a member of the board of advisors of Kum & Go since 2005. Mr. Hadley previously served as Chairman of RS Energy Group from 2017 until its acquisition by Enverus in February 2020. Mr. Hadley was selected to serve on our board of directors due to his significant experience in software and financial data and his track record as CEO of FactSet. Noreen Roth Henig, M.D. has agreed to serve on our board of directors on the effective date of the registration statement of which this prospectus is a part. Dr. Henig is the Chief Medical Officer of Kezar Life Sciences, Inc., a clinical-stage biotechnology company committed to revolutionizing treatments for patients with autoimmune diseases and cancer. Prior to Kezar Life Sciences, Inc., Dr. Henig served as Chief Medical Officer of Breath Therapeutics Holdings BV, a biotechnology company developing a first-in-class inhaled drug-device 120 Table of Contents therapy that was recently acquired by Zambon SpA. Prior to joining Breath Therapeutics Holding BV, she was Chief Medical Officer at ProQR Therapeutics N.V., a private company that completed an initial public offering as a preclinical phase biotechnology company. Since 2019, Dr. Henig has also served on the board of directors of Avidity Biosciences, which recently completed its initial public offering as a preclinical company in June 2020. Dr. Henig holds a B.A. in History of Art from Yale University and an M.D. with distinction in Immunology from Albert Einstein College of Medicine of Yeshiva University. Dr. Henig was selected to serve on our board of directors due to her extensive management and business background, particularly in the area of healthcare and biotech. Selina Tobaccowala has agreed to serve on our board of directors on the effective date of the registration statement of which this prospectus is a part. Ms. Tobaccowala is currently the Chief Digital Officer at Openfit, LLC, an all-in-one digital streaming platform for integrated fitness, nutrition and wellness. Prior to joining Openfit, LLC, she was the co-founder and CEO at Gixo, Inc., an innovative live workout fitness start-up, from 2016 until they were acquired by Openfit, LLC in 2019. Prior to Gixo Inc., Ms. Tobaccowala was the President and Chief Technology Officer at SurveyMonkey Inc. from 2009 to 2016, leading the company to become the world’s dominant online survey platform. She received a B.S. in Computer Science with Honors from Stanford University. Ms. Tobaccowala has served on the board of directors of Redfin since 2014 and as an advisory board member of HubSpot since 2015. Ms. Tobaccowala was selected to serve on our board of directors due to her considerable experience as an entrepreneur and software product executive. Number and Terms of Office of Officers and Directors Our Directors Our board of directors is divided into three classes, with only one class of directors being appointed in each year, and with each class (except for those directors appointed prior to our first annual general meeting) serving a three-year term. In accordance with the Nasdaq corporate governance requirements, we are not required to hold an annual general meeting until one year after our first fiscal year end following our listing on the Nasdaq. The term of office of the first class of directors, consisting of Mr. Berlew, Mr. Cros and Ms. Deignan, will expire at our first annual general meeting. The term of office of the second class of directors, consisting of Dr. Henig, Mr. Ofir and Ms. Tobaccowala, will expire at our second annual general meeting. The term of office of the third class of directors, consisting of Mr. Hadley and Mr. Stern, will expire at our third annual general meeting. Prior to the completion of an initial business combination, any vacancy on the board of directors may be filled by a nominee chosen by holders of a majority of our founder shares or by the affirmative vote of a majority of the directors present and voting at a meeting of our board. In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason. Holders of our public shares will not have the right to vote on the election or removal of directors prior to the completion of an initial business combination. Pursuant to an agreement to be entered into on or prior to the closing of this offering, our sponsor, upon and following consummation of an initial business combination, will be entitled to nominate three individuals for appointment to our board of directors, as long as our sponsor holds any securities covered by the registration and shareholder rights agreement. Our Officers Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set 121 Table of Contents forth in our amended and restated memorandum and articles of association as it deems appropriate. Our amended and restated memorandum and articles of association will provide that our officers may consist of one or more chairman of the board, chief executive officer, president, chief financial officer, vice presidents, secretary, treasurer and such other offices as may be determined by the board of directors. Director Independence The Nasdaq listing standards require that a majority of our board of directors be independent, subject to certain phase-in provisions. An “independent director” is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which, in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our board of directors has determined that each of Adam Berlew, Pierre-Yves Cros, Philip Hadley, Noreen Roth Henig and Selina Tobaccowala are “independent directors” as defined in the Nasdaq listing standards. Our independent directors will have regularly scheduled meetings at which only independent directors are present. Controlled Company Status After completion of this offering and until the completion of our initial business combination, only holders of our founder shares will have the right to vote on the election of directors. As a result, the Nasdaq will consider us to be a “controlled company” within the meaning of the Nasdaq corporate governance standards. Under the Nasdaq corporate governance standards, a company of which more than 50% of the voting power is held by an individual, group or another company is a “controlled company” and may elect not to comply with certain corporate governance requirements. We do not intend to utilize these exemptions and intend to comply with the corporate governance requirements of the Nasdaq, subject to applicable phase-in rules. However, if we determine in the future to utilize some or all of these exemptions, you will not have the same protections afforded to shareholders of companies that are subject to all of the Nasdaq corporate governance requirements. Officer and Director Compensation None of our officers or directors have received any cash compensation for services rendered to us. However, Mr. Stern, our Executive Chairman, Mr. Ofir, our Chief Executive Officer, and Ms. Deignan, our Chief Financial Officer, are also currently President, Managing Director and Managing Director, respectively, of Lazard and receive compensation from Lazard. In addition, our sponsor transferred 25,000 founder shares to each of our independent director nominees (none of which are subject to forfeiture in the event that the underwriters’ over-allotment option is not exercised in full). Further, Lazard has awarded each of our officers membership interests in a series of our sponsor (the “Employee Participation Interests”) pursuant to which our officers will have economic interests in certain of the founder shares but will not have voting rights or dispositive power with respect thereto. In particular, as of the date of this prospectus, our officers are expected to have an economic interest in respect of % in the aggregate of our issued and outstanding founder shares attributable to their Employee Participation Interests. Each of our officers will also be eligible to directly or indirectly receive additional economic or other interests in our securities from Lazard, including additional Employee Participation Interests, on a discretionary basis in the future. Commencing on the date that our securities are first listed on the Nasdaq through the earlier of consummation of our initial business combination and our liquidation, we will reimburse an affiliate of our sponsor for office space, secretarial and administrative services provided to us in the amount of $20,000 per month. In addition, our sponsor, members of our management team and their respective affiliates, including Lazard FrĂšres & Co. LLC, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable 122 Table of Contents business combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our sponsor, any member of our management team or their respective affiliates. Any such payments prior to an initial business combination will be made using funds held outside the trust account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional controls in place governing our reimbursement payments to our directors and officers for their out-of-pocket expenses incurred in connection with our activities on our behalf in connection with identifying and consummating an initial business combination. After the completion of our initial business combination, members of our management team who remain with us may be paid consulting or management fees from the combined company. All of these fees will be described, to the extent then known, in the proxy solicitation materials or tender offer materials furnished to our shareholders in connection with a proposed business combination. We have not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation will be known at the time of the proposed business combination, because the directors of the post-transaction business will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined, or recommended to the board of directors for determination, either by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our board of directors. We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business, but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our officers and directors that provide for benefits upon termination of employment. Committees of the Board of Directors Upon the effectiveness of the registration statement of which this prospectus forms a part, our board of

Holder Stats

1 0
% of Shares Held by All Insider 0.00%
% of Shares Held by Institutions 85.96%
% of Float Held by Institutions 85.96%
Number of Institutions Holding Shares 118

Mutual Fund Holders

Holder Shares Date Reported Value % Out
RiverNorth/DoubleLine Strategic Income Fund 607451 2022-03-30 5953019 1.06
Blackstone Alternative Multi-Strategy Fund 450000 2022-03-30 4410000 0.7800000000000001
Merger Fund, The 440843 2022-03-30 4320261 0.77
First Tr Exchange Traded Fd-First Trust Merger Arbitrage Fd 159340 2022-03-30 1561532 0.27999999999999997
Saba Capital Income & Opportunities Fd 64054 2022-04-29 629010 0.11
RiverNorth/DoubleLine Strategic Opportunity Fund 50000 2022-03-30 490000 0.09
RiverNorth Opportunities Fd 40000 2022-04-29 392800 0.07
Fidelity NASDAQ Composite Index Fund 32863 2022-05-30 321728 0.06
JNL Series Trust-JNL/Multi Manager Alternative Fund 20727 2022-03-30 203124 0.04
ETF Series Solutions-Defiance Next Gen SPAC Derived ETF 7337 2022-03-30 71902 0.01

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2022-08-24 Prelude Capital Management LLC 368,372 $3,610,000 0.1% +68.0% 0.513%
2022-08-23 Captrust Financial Advisors 4,325 $42,000 0.0% 0 0.006%
2022-08-18 Goldman Sachs Group Inc. 805,956 $7,900,000 0.0% -5.6% 1.121%
2022-08-17 Nomura Holdings Inc. 720,049 $7,060,000 0.0% +69.1% 1.002%
2022-08-17 Centiva Capital LP 210,232 $2,060,000 0.0% +4.1% 0.292%
2022-08-16 Captrust Financial Advisors 4,325 $42,000 0.0% 0 0.006%
2022-08-16 Woodline Partners LP 512,450 $5,020,000 0.1% +46.4% 0.713%
2022-08-16 CSS LLC IL 82,321 $810,000 0.0% -59.6% 0.115%
2022-08-16 Centiva Capital LP 210,232 $2,060,000 0.0% +4.1% 0.292%
2022-08-15 Cubist Systematic Strategies LLC 28,718 $280,000 0.0% 0 0.040%
2022-08-15 Citadel Advisors LLC 1,372,876 $13,430,000 0.0% -40.1% 1.910%
2022-08-15 Millennium Management LLC 2,133,760 $20,910,000 0.0% +4.6% 2.969%
2022-08-15 Nomura Holdings Inc. 720,049 $7,060,000 0.0% +69.1% 1.002%
2022-08-15 Bulldog Investors LLP 39,735 $390,000 0.1% 0 0.055%
2022-08-15 Linden Advisors LP 41,009 $400,000 0.0% -93.7% 0.057%
2022-08-13 Virtu Financial LLC 23,111 $230,000 0.0% 0 0.032%
2022-08-12 Sculptor Capital LP 2,307,781 $22,620,000 0.2% -12.0% 3.211%
2022-08-11 Toronto Dominion Bank 217,855 $2,130,000 0.0% +27.7% 0.303%
2022-08-11 Deutsche Bank AG 500,000 $4,900,000 0.0% +4.0% 0.696%
2022-08-11 UBS Group AG 15,726 $150,000 0.0% +2,412.1% 0.022%
2022-08-09 Arena Capital Advisors LLC CA 17,500 $170,000 0.0% -91.7% 0.024%
2022-08-05 Mint Tower Capital Management B.V. 225,000 $2,210,000 0.2% 0 0.313%
2022-08-02 Hartree Partners LP 250,000 $2,450,000 0.6% 0 0.348%
2022-07-29 Myriad Asset Management US LP 75,000 $740,000 0.2% 0 0.104%
2022-07-22 Wealthspring Capital LLC 11,965 $120,000 0.0% 0 0.017%
2022-06-07 Bank of America Corp DE 614,400 $6,020,000 0.0% +54.9% 0.855%
2022-06-01 Taconic Capital Advisors LP 290,000 $2,840,000 0.1% 0 0.403%
2022-05-23 Cantor Fitzgerald L. P. 1,146,511 $11,240,000 0.8% +74.8% 1.595%
2022-05-20 Sculptor Capital LP 2,622,405 $25,700,000 0.2% +420.4% 3.649%
2022-05-18 Nomura Holdings Inc. 425,794 $4,179,999 0.0% +26.2% 0.592%
2022-05-17 Glazer Capital LLC 3,969,343 $38,900,000 1.1% +23.3% 5.522%
2022-05-17 Royal Bank of Canada 6,122 $60,000 0.0% 0 0.009%
2022-05-17 Radcliffe Capital Management L.P. 1,074,899 $10,530,000 0.2% +26.5% 1.495%
2022-05-17 Saba Capital Management L.P. 1,053,986 $10,330,000 0.1% +26.8% 1.466%
2022-05-16 Goldman Sachs Group Inc. 854,150 $8,369,999 0.0% +41.0% 1.188%
2022-05-16 Kohlberg Kravis Roberts & Co. L.P. 87,891 $860,000 0.0% 0 0.122%
2022-05-16 Rivernorth Capital Management LLC 805,000 $7,890,000 0.3% +18.4% 1.120%
2022-05-16 RP Investment Advisors LP 699,970 $6,860,000 1.0% -36.5% 0.974%
2022-05-16 Aristeia Capital LLC 1,500,000 $14,700,000 0.3% 0 2.087%
2022-05-16 Wellington Management Group LLP 442,701 $4,340,000 0.0% -56.7% 0.616%
2022-05-16 Prelude Capital Management LLC 219,227 $2,150,000 0.1% +19.9% 0.305%
2022-05-13 Penserra Capital Management LLC 7,229 $70,000 0.0% -42.2% 0.010%
2022-05-13 Basso Capital Management L.P. 294,252 $2,880,000 0.3% 0 0.409%
2022-05-13 Arena Capital Advisors LLC CA 210,815 $2,069,999 0.3% -29.1% 0.293%
2022-05-13 P Schoenfeld Asset Management LP 316,519 $3,100,000 0.2% +262.8% 0.440%
2022-05-13 EMG Holdings L.P. 53,588 $530,000 0.0% -2.6% 0.075%
2022-05-12 HighTower Advisors LLC 693,550 $6,800,000 0.0% -2.4% 0.965%
2022-05-11 JPMorgan Chase & Co. 100,006 $980,000 0.0% 0 0.139%
2022-05-11 DG Capital Management LLC 127,155 $1,250,000 0.2% -15.3% 0.177%
2022-05-10 Privium Fund Management UK Ltd 25,000 $250,000 0.1% 0 0.035%
2022-05-09 Qube Research & Technologies Ltd 12,809 $130,000 0.0% -60.5% 0.018%
2022-05-04 Wolverine Asset Management LLC 109,482 $1,070,000 0.0% -5.0% 0.152%
2022-04-13 Exos Asset Management LLC 83,698 $820,000 0.4% +4.6% 0.116%
2022-03-14 Exos Asset Management LLC 80,000 $780,000 0.4% 0 0.111%
2022-02-22 DLD Asset Management LP 43,210 $420,000 0.0% 0 0.060%
2022-02-16 PenderFund Capital Management Ltd. 6,500 $80,000 0.0% +400.0% 0.009%
2022-02-15 Kepos Capital LP 675,000 $6,570,000 0.5% 0 0.939%
2022-02-15 Marshall Wace LLP 2,692,165 $26,200,000 0.0% +41.1% 3.746%
2022-02-14 D. E. Shaw & Co. Inc. 871,187 $8,480,000 0.0% +5.6% 1.212%
2022-02-14 Citadel Advisors LLC 2,292,267 $22,300,000 0.0% +34.8% 3.189%
2022-02-14 Glazer Capital LLC 3,219,615 $31,330,000 0.8% +2,104.9% 4.479%
2022-02-14 CSS LLC IL 299,337 $2,910,000 0.1% -18.4% 0.416%
2022-02-14 Sage Rock Capital Management LP 555,005 $5,400,000 0.8% 0 0.772%
2022-02-11 PEAK6 Investments LLC 107,703 $1,050,000 0.0% +7.6% 0.150%
2022-02-10 Qube Research & Technologies Ltd 32,451 $320,000 0.0% -21.4% 0.045%
2022-02-10 HighTower Advisors LLC 710,275 $6,910,000 0.0% -1.8% 0.988%
2022-02-09 Wolverine Asset Management LLC 115,273 $1,120,000 0.0% -4.0% 0.160%
2022-02-09 Context Capital Management LLC 117,627 $1,150,000 0.1% -59.8% 0.164%
2022-02-08 Bank of America Corp DE 396,559 $3,860,000 0.0% 0 0.552%
2022-02-04 Toronto Dominion Bank 170,601 $1,660,000 0.0% +26.4% 0.237%
2022-02-02 Evolution Capital Management LLC 20,000 $200,000 0.6% 0 0.028%
2022-02-01 Qube Research & Technologies Ltd 32,451 $320,000 0.0% -21.4% 0.045%
2022-01-27 Brown Advisory Inc. 12,000 $120,000 0.0% 0 0.017%
2022-01-19 Cantor Fitzgerald Investment Adviser L.P. 169,650 $1,650,000 0.1% 0 0.236%
2021-12-29 Hudson Bay Capital Management LP 1,205,335 $11,730,000 0.1% -4.9% 1.677%
2021-11-16 Schonfeld Strategic Advisors LLC 13,634 $130,000 0.0% 0 0.019%
2021-11-16 Easterly Investment Partners LLC 15,000 $150,000 0.0% -39.8% 0.021%
2021-11-16 Jane Street Group LLC 183,922 $1,790,000 0.0% +16.2% 0.256%
2021-11-16 Wellington Management Group LLP 1,023,083 $9,960,000 0.0% +47.8% 1.423%
2021-11-16 Beryl Capital Management LLC 385,251 $3,750,000 0.3% 0 0.536%
2021-11-16 Citadel Advisors LLC 1,701,084 $16,550,000 0.0% +87.4% 2.367%
2021-11-16 CNH Partners LLC 69,650 $680,000 0.0% +39.3% 0.097%
2021-11-15 Rivernorth Capital Management LLC 550,000 $5,350,000 0.3% +10.0% 0.765%
2021-11-15 Marshall Wace LLP 1,908,017 $18,570,000 0.1% +36.4% 2.655%
2021-11-15 Westchester Capital Management LLC 50,000 $490,000 0.0% 0 0.070%
2021-11-15 Omni Partners US LLC 37,137 $360,000 0.0% -3.6% 0.052%
2021-11-15 Glazer Capital LLC 146,024 $1,420,000 0.0% -3.0% 0.203%
2021-11-15 CSS LLC IL 366,675 $3,570,000 0.2% +685.6% 0.510%
2021-11-15 Hudson Bay Capital Management LP 1,205,335 $11,730,000 0.2% -4.9% 1.677%
2021-11-15 Penserra Capital Management LLC 9,487 $92,000 0.0% 0 0.013%
2021-11-15 Context Advisory LLC 292,627 $2,850,000 0.3% 0 0.407%
2021-11-15 HighTower Advisors LLC 723,545 $7,040,000 0.0% +2.2% 1.007%
2021-11-12 Periscope Capital Inc. 621,150 $6,040,000 0.2% +39.0% 0.864%
2021-11-12 Arena Capital Advisors LLC CA 517,500 $5,040,000 0.4% +197.8% 0.720%
2021-11-12 Weiss Asset Management LP 395,750 $3,850,000 0.1% 0 0.551%
2021-11-12 Wolverine Asset Management LLC 120,072 $1,170,000 0.0% +25.9% 0.167%
2021-11-12 Magnetar Financial LLC 10,331 $100,000 0.0% 0 0.014%
2021-11-10 Goldman Sachs Group Inc. 605,950 $5,900,000 0.0% -0.7% 0.843%
2021-11-10 Healthcare of Ontario Pension Plan Trust Fund 453,400 $4,410,000 0.0% 0 0.631%
2021-11-10 Alliancebernstein L.P. 149,555 $1,460,000 0.0% -25.8% 0.208%

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q 10-Q 2022-08-10 https://www.sec.gov/Archives/edgar/data/1836337/000156459022028939/lgacu-10q_20220630.htm
10-Q 10-Q 2022-05-11 https://www.sec.gov/Archives/edgar/data/1836337/000156459022019555/lgacu-10q_20220331.htm
10-K 10-K 2022-03-31 https://www.sec.gov/Archives/edgar/data/1836337/000156459022012745/lgacu-10k_20211231.htm
SC 13G 2022-02-14 https://www.sec.gov/Archives/edgar/data/1836337/000107680922000035/lgac20211231.htm
5 2022-02-10 https://www.sec.gov/Archives/edgar/data/1836337/000095015722000118/xslF345X03/form5.xml
SC 13G/A 2022-02-04 https://www.sec.gov/Archives/edgar/data/1836337/000131924422000089/LGAC_SC13GA1.htm
SC 13G 2022-01-31 https://www.sec.gov/Archives/edgar/data/1836337/000095015722000072/sc13g.htm
10-Q/A 10-Q/A 2021-12-17 https://www.sec.gov/Archives/edgar/data/1836337/000156459021060656/lgacu-10qa_20210930.htm
8-K 8-K 2021-12-16 https://www.sec.gov/Archives/edgar/data/1836337/000156459021060476/lgacu-8k_20211213.htm
10-Q 10-Q 2021-11-04 https://www.sec.gov/Archives/edgar/data/1836337/000156459021054539/lgacu-10q_20210930.htm
10-Q 10-Q 2021-08-09 https://www.sec.gov/Archives/edgar/data/1836337/000156459021042260/lgacu-10q_20210630.htm
4 2021-06-08 https://www.sec.gov/Archives/edgar/data/1836337/000095015721000603/xslF345X03/form4.xml
4 2021-06-08 https://www.sec.gov/Archives/edgar/data/1836337/000095015721000602/xslF345X03/form4.xml
4 2021-06-08 https://www.sec.gov/Archives/edgar/data/1836337/000095015721000601/xslF345X03/form4.xml
10-Q 10-Q 2021-05-12 https://www.sec.gov/Archives/edgar/data/1836337/000156459021027071/lgacu-10q_20210331.htm
8-K 8-K 2021-04-02 https://www.sec.gov/Archives/edgar/data/1836337/000119312521105188/d154093d8k.htm
10-K 10-K 2021-03-31 https://www.sec.gov/Archives/edgar/data/1836337/000156459021017076/lgacu-10k_20201231.htm
SC 13G 2021-02-24 https://www.sec.gov/Archives/edgar/data/1836337/000131924421000145/LGAC_SC13G.htm
8-K 8-K 2021-02-19 https://www.sec.gov/Archives/edgar/data/1836337/000119312521049088/d136952d8k.htm
8-K 8-K 2021-02-12 https://www.sec.gov/Archives/edgar/data/1836337/000119312521041745/d69997d8k.htm
424B4 424B4 2021-02-11 https://www.sec.gov/Archives/edgar/data/1836337/000119312521038763/d127595d424b4.htm
EFFECT 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/999999999521000530/xslEFFECTX01/primary_doc.xml
CERT 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000135445721000201/8A_Cert_LGAC.pdf
3 FORM 3 SUBMISSION 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000089924321005408/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000089924321005405/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000089924321005404/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000089924321005402/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000089924321005401/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000089924321005397/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000089924321005396/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000089924321005392/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000089924321005391/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000089924321005390/xslF345X02/doc3.xml
CORRESP 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000119312521033544/filename1.htm
CORRESP 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000119312521033534/filename1.htm
8-A12B 8-A12B 2021-02-09 https://www.sec.gov/Archives/edgar/data/1836337/000119312521033449/d72343d8a12b.htm
CORRESP 2021-02-08 https://www.sec.gov/Archives/edgar/data/1836337/000119312521031898/filename1.htm
S-1/A S-1/A 2021-02-08 https://www.sec.gov/Archives/edgar/data/1836337/000119312521031865/d127595ds1a.htm
UPLOAD 2021-02-05 https://www.sec.gov/Archives/edgar/data/1836337/000000000021001543/filename1.pdf
S-1/A S-1/A 2021-02-02 https://www.sec.gov/Archives/edgar/data/1836337/000119312521025384/d304219ds1a.htm
CORRESP 2021-01-25 https://www.sec.gov/Archives/edgar/data/1836337/000119312521016614/filename1.htm
S-1 S-1 2021-01-25 https://www.sec.gov/Archives/edgar/data/1836337/000119312521016469/d304219ds1.htm
UPLOAD 2021-01-14 https://www.sec.gov/Archives/edgar/data/1836337/000000000021000486/filename1.pdf
DRSLTR 2020-12-18 https://www.sec.gov/Archives/edgar/data/1836337/000095012320012750/filename1.htm
DRS 2020-12-18 https://www.sec.gov/Archives/edgar/data/1836337/000095012320012749/filename1.htm